Total Payments
$1.2M
2024 Payments
$65,127
Companies
13
Transactions
1,120
Medicare Patients
22
Medicare Billing
$298.82
Payment Breakdown by Category
Other$863,868 (73.6%)
Travel$183,812 (15.7%)
Consulting$97,743 (8.3%)
Food & Beverage$27,434 (2.3%)
Research$1,155 (0.1%)
Education$3.10 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $782,089 | 242 | 66.6% |
| Travel and Lodging | $183,812 | 453 | 15.7% |
| Consulting Fee | $97,743 | 39 | 8.3% |
| Honoraria | $50,843 | 15 | 4.3% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $30,437 | 9 | 2.6% |
| Food and Beverage | $27,434 | 359 | 2.3% |
| Unspecified | $1,155 | 1 | 0.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $500.00 | 1 | 0.0% |
| Education | $3.10 | 1 | 0.0% |
Payments by Type
General
$1.2M
1,119 transactions
Research
$1,155
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $984,548 | 925 | $0 (2024) |
| Blueprint Medicines Corporation | $62,330 | 74 | $0 (2022) |
| Foundation Medicine, Inc. | $49,024 | 27 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $48,782 | 58 | $0 (2023) |
| Roche Diagnostics Corporation | $9,888 | 14 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $8,925 | 7 | $0 (2019) |
| AbbVie, Inc. | $4,338 | 8 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $3,685 | 2 | $0 (2021) |
| ROCHE SEQUENCING SOLUTIONS, INC. | $1,500 | 1 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $842.00 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $65,127 | 62 | AstraZeneca Pharmaceuticals LP ($65,127) |
| 2023 | $169,005 | 155 | AstraZeneca Pharmaceuticals LP ($168,740) |
| 2022 | $140,147 | 143 | AstraZeneca Pharmaceuticals LP ($87,321) |
| 2021 | $161,245 | 158 | AstraZeneca Pharmaceuticals LP ($145,531) |
| 2020 | $148,258 | 131 | AstraZeneca Pharmaceuticals LP ($144,641) |
| 2019 | $195,259 | 178 | AstraZeneca Pharmaceuticals LP ($168,916) |
| 2018 | $108,911 | 119 | AstraZeneca Pharmaceuticals LP ($66,185) |
| 2017 | $186,065 | 174 | AstraZeneca Pharmaceuticals LP ($138,087) |
All Payment Transactions
1,120 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | Cash or cash equivalent | $22.06 | General |
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 11/23/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $12.64 | General |
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,840.00 | General |
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | In-kind items and services | $991.42 | General |
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | In-kind items and services | $386.92 | General |
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | In-kind items and services | $164.10 | General |
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $125.50 | General |
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $77.61 | General |
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $70.17 | General |
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,840.00 | General |
| Category: Oncology | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,840.00 | General |
| Category: Oncology | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Travel and Lodging | In-kind items and services | $1,690.24 | General |
| Category: Oncology | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Travel and Lodging | In-kind items and services | $735.82 | General |
| Category: Oncology | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Travel and Lodging | In-kind items and services | $172.36 | General |
| Category: Oncology | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $121.60 | General |
| Category: Oncology | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $52.97 | General |
| Category: Oncology | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $51.56 | General |
| Category: Oncology | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Travel and Lodging | In-kind items and services | $30.68 | General |
| Category: Oncology | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $29.18 | General |
| Category: Oncology | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Oncology | ||||||
| 10/05/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Travel and Lodging | In-kind items and services | $202.74 | General |
| Category: Oncology | ||||||
| 10/05/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Oncology | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,840.00 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Non-Interventional Primary Data Collection Study to Assess the Prevalence of PD-L1 High in First Line Metastatic and Locally Advanced Urothelial Carcinoma Study (mUC) | AstraZeneca Pharmaceuticals LP | $1,155 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 1 | 22 | 22 | $1,378 | $298.82 |
Total Patients
22
Total Services
22
Medicare Billing
$298.82
Procedure Codes
1
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0452 | Molecular pathology procedure; physician interpretation and report | Facility | 2020 | 22 | 22 | $1,378 | $298.82 | 21.7% |
About Dr. Jeffrey Gregg, M.D
Dr. Jeffrey Gregg, M.D is a Specialist healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689657918.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Gregg, M.D has received a total of $1.2M in payments from pharmaceutical and medical device companies, with $65,127 received in 2024. These payments were reported across 1,120 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($782,089).
As a Medicare-enrolled provider, Gregg has provided services to 22 Medicare beneficiaries, totaling 22 services with total Medicare billing of $298.82. Data is available for 1 year (2020–2020), covering 1 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Sacramento, CA
- Active Since 11/21/2005
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1689657918
Products in Payments
- TAGRISSO (Drug) $676,600
- LYNPARZA (Drug) $156,649
- GAVRETO (Drug) $58,223
- IMFINZI (Biological) $42,541
- FOUNDATIONACT (Device) $35,178
- IMFINZI (Drug) $23,821
- FOUNDATIONONE LIQUID (Device) $13,016
- OPDIVO (Biological) $11,716
- PIQRAY (Drug) $6,612
- MD cobas Instruments and Reagents (Device) $5,049
- AYVAKIT (Drug) $4,107
- EXKIVITY (Drug) $3,685
- RS Sequencing Reagents and Assays (Device) $2,440
- AVENIO Millisect (Device) $2,400
- BYL719 (Drug) $1,710
- SEQUENCING REAGENTS & ASSAYS (Device) $1,500
- Vitrakvi (Drug) $842.00
- FOUNDATIONONE (Device) $830.51
- clonoSEQ (Device) $44.45
- MEKINIST (Drug) $18.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Sacramento
Mehrad Abedi, M.d, M.D
Specialist — Payments: $809,018
Specialist $809,018
Dr. Nancy Lane, M.d, M.D
Specialist — Payments: $434,011
Specialist $434,011
Dr. Naveen Atray, M.d, M.D
Specialist — Payments: $99,483
Specialist $99,483
David Pai, Md, MD
Specialist — Payments: $37,989
Specialist $37,989
William Cushard, M.d, M.D
Specialist — Payments: $31,555
Specialist $31,555
Dr. Christopher Polage, M.d, M.D
Specialist — Payments: $18,465
Specialist $18,465